The Leukaemia Foundation is funding a cutting-edge diagnostic test that would help clinicians identify specific gene mutations to offer more effective, targeted treatments for Australians living with blood cancer.
The SA Genomics Haematology Malignancies Node will have the first of three tests available across Australia in six months. This first test, which will sequence 38 genes at the same time – would initially be for people living with a range of myeloid neoplasms – allowing clinicians to identify mutations and then treat them with precision medicines, specific to that genetic anomaly.
At this time next year, clinicians would have access to a second test for myeloma – and a third innovative test for lymphoid malignancies would also be well into development.
Read the whole story here.